| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | -5.79% | Wedbush | → $140 | Reiterates | Neutral → Neutral |
| 10/26/2023 | 20.46% | RBC Capital | $188 → $179 | Maintains | Outperform |
| 10/26/2023 | 4.31% | BMO Capital | $152 → $155 | Maintains | Market Perform |
| 10/26/2023 | -5.79% | Wedbush | → $140 | Reiterates | Neutral → Neutral |
| 10/17/2023 | -12.52% | Morgan Stanley | $135 → $130 | Maintains | Equal-Weight |
| 09/20/2023 | 26.51% | RBC Capital | → $188 | Initiates Coverage On | → Outperform |
| 07/20/2023 | 7.67% | B of A Securities | $152 → $160 | Maintains | Buy |
| 07/20/2023 | -3.1% | Stifel | $140 → $144 | Maintains | Buy |
| 07/20/2023 | -9.15% | Morgan Stanley | $135 → $135 | Reiterates | Equal-Weight → Equal-Weight |
| 07/20/2023 | -5.79% | Wedbush | → $140 | Reiterates | Neutral → Neutral |
| 07/20/2023 | 2.29% | BMO Capital | $150 → $152 | Maintains | Market Perform |
| 07/17/2023 | 0.94% | BMO Capital | $145 → $150 | Maintains | Market Perform |
| 07/12/2023 | -9.15% | Morgan Stanley | $135 → $135 | Reiterates | Equal-Weight → Equal-Weight |
| 07/11/2023 | 9.02% | Credit Suisse | → $162 | Reiterates | Outperform → Outperform |
| 07/07/2023 | -2.42% | JP Morgan | → $145 | Initiates Coverage On | → Neutral |
| 06/26/2023 | 9.02% | Credit Suisse | $162 → $162 | Reiterates | Outperform → Outperform |
| 04/27/2023 | -5.79% | Wedbush | → $140 | Reiterates | → Neutral |
| 04/20/2023 | -2.42% | BMO Capital | $155 → $145 | Maintains | Market Perform |
| 04/20/2023 | -5.79% | Evercore ISI Group | $150 → $140 | Maintains | In-Line |
| 04/20/2023 | -5.79% | Stifel | $150 → $140 | Maintains | Buy |
| 04/20/2023 | -9.15% | Morgan Stanley | $143 → $135 | Maintains | Equal-Weight |
| 04/13/2023 | 9.02% | Credit Suisse | $165 → $162 | Maintains | Outperform |
| 02/06/2023 | — | Edward Jones | Downgrades | Buy → Hold | |
| 01/26/2023 | -2.42% | Citigroup | $140 → $145 | Maintains | Neutral |
| 01/26/2023 | 4.31% | BMO Capital | $148 → $155 | Maintains | Market Perform |
| 01/23/2023 | 6.33% | Stifel | $140 → $158 | Maintains | Buy |
| 01/19/2023 | -5.79% | MoffettNathanson | → $140 | Upgrades | Underperform → Market Perform |
| 01/18/2023 | -0.4% | Morgan Stanley | $152 → $148 | Downgrades | Overweight → Equal-Weight |
| 10/20/2022 | 4.31% | Credit Suisse | $158 → $155 | Maintains | Outperform |
| 10/17/2022 | -5.79% | Stifel | $150 → $140 | Maintains | Buy |
| 10/06/2022 | 2.29% | Morgan Stanley | $155 → $152 | Maintains | Overweight |
| 07/20/2022 | 4.98% | Credit Suisse | $166 → $156 | Maintains | Outperform |
| 07/19/2022 | 4.31% | Morgan Stanley | $157 → $155 | Maintains | Overweight |
| 07/19/2022 | -0.4% | BMO Capital | $152 → $148 | Maintains | Market Perform |
| 04/21/2022 | -6.46% | Tigress Financial | $133 → $139 | Maintains | Neutral |
| 04/20/2022 | 5.65% | Morgan Stanley | $150 → $157 | Maintains | Overweight |
| 04/20/2022 | 2.29% | BMO Capital | $148 → $152 | Maintains | Market Perform |
| 04/20/2022 | 11.71% | Credit Suisse | $165 → $166 | Maintains | Outperform |
| 04/20/2022 | 11.04% | B of A Securities | $162 → $165 | Maintains | Buy |
| 04/14/2022 | 0.94% | Morgan Stanley | $147 → $150 | Upgrades | Equal-Weight → Overweight |
| 04/13/2022 | -0.4% | BMO Capital | $155 → $148 | Maintains | Market Perform |
| 01/25/2022 | 4.31% | BMO Capital | $153 → $155 | Maintains | Market Perform |
| 01/11/2022 | -16.55% | UBS | $136 → $124 | Downgrades | Neutral → Sell |
| 01/10/2022 | — | Goldman Sachs | Initiates Coverage On | → Neutral | |
| 10/21/2021 | 15.75% | Credit Suisse | $176 → $172 | Maintains | Outperform |
| 10/05/2021 | 18.44% | Credit Suisse | $167 → $176 | Maintains | Outperform |
| 10/01/2021 | 14.4% | Jefferies | → $170 | Initiates Coverage On | → Buy |
| 07/20/2021 | 10.36% | Morgan Stanley | $152 → $164 | Maintains | Equal-Weight |
| 07/20/2021 | 0.94% | Citigroup | $140 → $150 | Maintains | Neutral |
| 07/20/2021 | -5.79% | Societe Generale | $121 → $140 | Upgrades | Sell → Hold |
| 07/16/2021 | 4.31% | BMO Capital | $150 → $155 | Maintains | Market Perform |
| 04/20/2021 | 11.04% | Credit Suisse | $160 → $165 | Maintains | Outperform |
| 04/20/2021 | 0.94% | BMO Capital | $138 → $150 | Maintains | Market Perform |
| 04/20/2021 | 2.29% | Morgan Stanley | $150 → $152 | Maintains | Equal-Weight |
| 04/08/2021 | 0.94% | Morgan Stanley | $140 → $150 | Maintains | Equal-Weight |
| 10/20/2020 | -7.13% | BMO Capital | $140 → $138 | Maintains | Market Perform |
| 10/09/2020 | -5.79% | Morgan Stanley | $128 → $140 | Maintains | Equal-Weight |
| 07/22/2020 | 4.31% | Argus Research | → $155 | Upgrades | Hold → Buy |
| 07/21/2020 | -13.86% | Morgan Stanley | $111 → $128 | Maintains | Equal-Weight |
| 07/21/2020 | 4.31% | Credit Suisse | $150 → $155 | Maintains | Outperform |
| 04/22/2020 | -19.25% | Citigroup | $110 → $120 | Maintains | Neutral |
| 04/21/2020 | -25.3% | Morgan Stanley | $107 → $111 | Maintains | Equal-Weight |
| 04/21/2020 | -19.25% | UBS | $140 → $120 | Maintains | Neutral |
| 04/21/2020 | -5.79% | Wedbush | $155 → $140 | Maintains | Neutral |
| 04/15/2020 | -1.08% | Stifel | $169 → $147 | Maintains | Buy |
| 04/15/2020 | 0.94% | Credit Suisse | $173 → $150 | Maintains | Outperform |
| 04/14/2020 | -19.25% | Wells Fargo | $145 → $120 | Maintains | Equal-Weight |
| 03/25/2020 | -27.99% | Morgan Stanley | $164 → $107 | Maintains | Equal-Weight |
| 03/23/2020 | -9.15% | Nomura | $170 → $135 | Maintains | Buy |
| 02/03/2020 | — | Edward Jones | Upgrades | Hold → Buy | |
| 01/22/2020 | 10.36% | Morgan Stanley | $155 → $164 | Maintains | Equal-Weight |
| 01/22/2020 | -7.13% | Cantor Fitzgerald | $133 → $138 | Maintains | Neutral |
| 01/22/2020 | 4.31% | Citigroup | $140 → $155 | Maintains | Neutral |
| 01/17/2020 | 4.31% | Morgan Stanley | $170 → $155 | Downgrades | Overweight → Equal-Weight |
| 01/13/2020 | -2.42% | Evercore ISI Group | → $145 | Downgrades | Outperform → In-Line |
| 10/21/2019 | -5.79% | UBS | $170 → $140 | Downgrades | Buy → Neutral |
| 10/17/2019 | -5.79% | Wells Fargo | $147 → $140 | Maintains | Market Perform |
| 10/17/2019 | 2.29% | BMO Capital | $157 → $152 | Maintains | Market Perform |
| 10/17/2019 | 4.31% | Wedbush | $165 → $155 | Maintains | Neutral |
| 10/17/2019 | 14.4% | Nomura | $175 → $170 | Maintains | Buy |
| 08/06/2019 | -1.08% | Wells Fargo | $140 → $147 | Maintains | Market Perform |
| 08/05/2019 | 17.77% | Nomura | $165 → $175 | Maintains | Buy |
| 08/05/2019 | 14.4% | B of A Securities | $165 → $170 | Maintains | Buy |
| 08/01/2019 | 14.4% | Morgan Stanley | → $170 | Reinstates | → Overweight |
| 07/18/2019 | 11.04% | Nomura | $160 → $165 | Maintains | Buy |
| 07/18/2019 | -1.08% | JP Morgan | → $147 | Reinstates | → Neutral |
| 06/06/2019 | 0.94% | Evercore ISI Group | → $150 | Initiates Coverage On | → Outperform |
| 04/17/2019 | -5.79% | Citigroup | $130 → $140 | Maintains | Neutral |
| 04/17/2019 | 4.31% | BMO Capital | $147 → $155 | Maintains | Market Perform |
| 04/11/2019 | 16.42% | Credit Suisse | → $173 | Initiates Coverage On | → Outperform |
| 12/17/2018 | 12.38% | RBC Capital | $175 → $167 | Maintains | Outperform |
What is the target price for IBM (IBM)?
The latest price target for IBM (NYSE: IBM) was reported by Wedbush on November 13, 2023. The analyst firm set a price target for $140.00 expecting IBM to fall to within 12 months (a possible -5.79% downside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IBM (IBM)?
The latest analyst rating for IBM (NYSE: IBM) was provided by Wedbush, and IBM reiterated their neutral rating.
When is the next analyst rating going to be posted or updated for IBM (IBM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IBM, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IBM was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating IBM (IBM) correct?
While ratings are subjective and will change, the latest IBM (IBM) rating was a reiterated with a price target of $0.00 to $140.00. The current price IBM (IBM) is trading at is $148.60, which is out of the analyst's predicted range.